RORγt+ hematopoietic cells are necessary for tumor cell proliferation during colitis-associated tumorigenesis in mice

European Journal of Immunology

Volumn 45, Issue 6, 2015, Pages 1667-1679

  Martin, Maria ^a   Kesselring, Rebecca K ^a   Saidou, Balam ^a   Brunner, Stefan M ^a   Schiechl, Gabriela ^a   Mouris, Verena F ^a   Wege, Anja K ^a   Rümmele, Petra ^a   Schlitt, Hans J ^a   Geissler, Edward K ^a   Fichtner Feigl, Stefan ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

AOM+DSS; Colitis associated colorectal cancer; IL 17; ROR t; Th17 cells

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 17; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR RELATED ORPHAN RECEPTOR GAMMA T; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; RETINOID RELATED ORPHAN RECEPTOR GAMMA;

ANIMAL CELL; ARTICLE; CANCER PATIENT; CARCINOGENESIS; CELL CULTURE; CELL PROLIFERATION; CHIMERA; COLITIS; COLITIS ASSOCIATED TUMORIGENESIS; COLON TUMOR; COLORECTAL CANCER; CYTOTOXICITY; FLOW CYTOMETRY; HEMATOPOIETIC CELL; HUMAN; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TH17 CELL; TUMOR CELL; TUMOR GROWTH; ULCERATIVE COLITIS; ANIMAL; CD4+ T LYMPHOCYTE; CELL TRANSFORMATION; COLONIC NEOPLASMS; COMPLICATION; DISEASE MODEL; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; TH1 CELL; TUMOR VOLUME;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; COLITIS; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; HUMANS; INTERLEUKIN-17; MICE; MICE, KNOCKOUT; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; TH1 CELLS; TH17 CELLS; TUMOR BURDEN;

EID: 84930414180     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201444915     Document Type: Article

References (57)

1. Kamangar, F., Dores, G. M. and Anderson, W. F., Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J. Clin. Oncol. 2006. 24: 2137-2150.
2. Terzic, J., Grivennikov, S., Karin, E. and Karin, M., Inflammation and colon cancer. Gastroenterology 2010. 138: 2101-2114 e2105.
3. Eaden, J. A., Abrams, K. R. and Mayberry, J. F., The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001. 48: 526-535.
4. Itzkowitz, S. H. and Yio, X., Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 2004. 287: G7-17.
5. Lakatos, P. L. and Lakatos, L., Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies. World J. Gastroenterol. 2008. 14: 3937-3947.
6. Clevers, H., At the crossroads of inflammation and cancer. Cell 2004. 118: 671-674.
7. Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z. W., Egan, L. J., Kagnoff, M. F. et al., IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004. 118: 285-296.
8. Lin, W. W. and Karin, M., A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Invest. 2007. 117: 1175-1183.
9. Bollrath, J., Phesse, T. J., vonBurstin, V. A., Putoczki, T., Bennecke, M., Bateman, T., Nebelsiek, T. et al., gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. Cancer Cell 2009. 15: 91-102.
10. Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G. Y., Vallabhapurapu, S., Scheller, J. et al., IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 2009. 15: 103-113.
11. Waldner, M. J. and Neurath, M. F., Colitis-associated cancer: the role of T cells in tumor development. Semin. Immunopathol. 2009. 31: 249-256.
12. Hundorfean, G., Neurath, M. F. and Mudter, J., Functional relevance of T helper 17 (Th17) cells and the IL-17 cytokine family in inflammatory bowel disease. Inflamm. Bowel Dis. 2012. 18: 180-186.
13. Ivanov, II, McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J. et al., The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006. 126: 1121-1133.
14. Yang, X. O., Pappu, B. P., Nurieva, R., Akimzhanov, A., Kang, H. S., Chung, Y., Ma, L. et al., T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 2008. 28: 29-39.
15. Iwakura, Y., Ishigame, H., Saijo, S. and Nakae, S., Functional specialization of interleukin-17 family members. Immunity 2011. 34: 149-162.
16. Rachitskaya, A. V., Hansen, A. M., Horai, R., Li, Z., Villasmil, R., Luger, D., Nussenblatt, R. B. et al., Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion. J. Immunol. 2008. 180: 5167-5171.
17. Kondo, T., Takata, H., Matsuki, F. and Takiguchi, M., Cutting edge: phenotypic characterization and differentiation of human CD8+ T cells producing IL-17. J. Immunol. 2009. 182: 1794-1798.
18. O'Brien, R. L., Roark, C. L. and Born, W. K., IL-17-producing gammadelta T cells. Eur. J. Immunol. 2009. 39: 662-666.
19. Spits, H. and Di Santo, J. P., The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat. Immunol. 2011. 12: 21-27.
20. Martinez, G. J., Nurieva, R. I., Yang, X. O. and Dong, C., Regulation and function of proinflammatory TH17 cells. Ann. N. Y. Acad. Sci. 2008. 1143: 188-211.
21. Jovanovic, D. V., Di Battista, J. A., Martel-Pelletier, J., Jolicoeur, F. C., He, Y., Zhang, M., Mineau, F. et al., IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J. Immunol. 1998. 160: 3513-3521.
22. Witowski, J., Pawlaczyk, K., Breborowicz, A., Scheuren, A., Kuzlan-Pawlaczyk, M., Wisniewska, J., Polubinska, A. et al., IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells. J. Immunol. 2000. 165: 5814-5821.
23. Fujino, S., Andoh, A., Bamba, S., Ogawa, A., Hata, K., Araki, Y., Bamba, T. et al., Increased expression of interleukin 17 in inflammatory bowel disease. Gut 2003. 52: 65-70.
24. Rovedatti, L., Kudo, T., Biancheri, P., Sarra, M., Knowles, C. H., Rampton, D. S., Corazza, G. R. et al., Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease. Gut 2009. 58: 1629-1636.
25. Zhang, Z., Zheng, M., Bindas, J., Schwarzenberger, P. and Kolls, J. K., Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflamm. Bowel Dis. 2006. 12: 382-388.
26. Leppkes, M., Becker, C., Ivanov, II, Hirth, S., Wirtz, S., Neufert, C., Pouly, S. et al., RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F. Gastroenterology 2009. 136: 257-267.
27. Elson, C. O., Cong, Y., Weaver, C. T., Schoeb, T. R., McClanahan, T. K., Fick, R. B. and Kastelein, R. A., Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice. Gastroenterology 2007. 132: 2359-2370.
28. Ito, R., Kita, M., Shin-Ya, M., Kishida, T., Urano, A., Takada, R., Sakagami, J. et al., Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice. Biochem. Biophys. Res. Commun. 2008. 377: 12-16.
29. Dieleman, L. A., Ridwan, B. U., Tennyson, G. S., Beagley, K. W., Bucy, R. P. and Elson, C. O., Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 1994. 107: 1643-1652.
30. Schwitalla, S., Ziegler, P. K., Horst, D., Becker, V., Kerle, I., Begus-Nahrmann, Y., Lechel, A. et al., Loss of p53 in enterocytes generates an inflammatory microenvironment enabling invasion and lymph node metastasis of carcinogen-induced colorectal tumors. Cancer Cell 2013. 23: 93-106.
31. Toft, N. J., Winton, D. J., Kelly, J., Howard, L. A., Dekker, M., te Riele, H., Arends, M. J. et al., Msh2 status modulates both apoptosis and mutation frequency in the murine small intestine. Proc. Natl. Acad. Sci. USA 1999. 96: 3911-3915.
32. Braumuller, H., Wieder, T., Brenner, E., Assmann, S., Hahn, M., Alkhaled, M., Schilbach, K. et al., T-helper-1-cell cytokines drive cancer into senescence. Nature 2013. 494: 361-365.
33. David, H., Rudolf Virchow and modern aspects of tumor pathology. Pathol. Res. Pract. 1988. 183: 356-364.
34. Hanahan, D. and Weinberg, R. A., Hallmarks of cancer: the next generation. Cell 2011. 144: 646-674.
35. Fridman, W. H., Pages, F., Sautes-Fridman, C. and Galon, J., The immune contexture in human tumours: impact on clinical outcome. Nat. Rev. Cancer 2012. 12: 298-306.
36. Benchetrit, F., Ciree, A., Vives, V., Warnier, G., Gey, A., Sautes-Fridman, C., Fossiez, F. et al., Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism. Blood 2002. 99: 2114-2121.
37. Tartour, E., Fossiez, F., Joyeux, I., Galinha, A., Gey, A., Claret, E., Sastre-Garau, X. et al., Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice. Cancer Res. 1999. 59: 3698-3704.
38. Wilke, C. M., Kryczek, I., Wei, S., Zhao, E., Wu, K., Wang, G. and Zou, W., Th17 cells in cancer: help or hindrance? Carcinogenesis 2011. 32: 643-649.
39. Murugaiyan, G. and Saha, B., Protumor vs antitumor functions of IL-17. J. Immunol. 2009. 183: 4169-4175.
40. Chae, W. J., Gibson, T. F., Zelterman, D., Hao, L., Henegariu, O. and Bothwell, A. L., Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis. Proc. Natl. Acad. Sci. USA 2010. 107: 5540-5544.
41. Wu, S., Rhee, K. J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H. R., Huso, D. L. et al., A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat. Med. 2009. 15: 1016-1022.
42. Zhang, Q., Liu, S., Ge, D., Xue, Y., Xiong, Z., Abdel-Mageed, A. B., Myers, L. et al., Interleukin-17 promotes formation and growth of prostate adenocarcinoma in mouse models. Cancer Res. 2012. 72: 2589-2599.
43. He, D., Li, H., Yusuf, N., Elmets, C. A., Li, J., Mountz, J. D. and Xu, H., IL-17 promotes tumor development through the induction of tumor promoting microenvironments at tumor sites and myeloid-derived suppressor cells. J. Immunol. 2010. 184: 2281-2288.
44. Reppert, S., Boross, I., Koslowski, M., Tureci, O., Koch, S., Lehr, H. A. and Finotto, S., A role for T-bet-mediated tumour immune surveillance in anti-IL-17A treatment of lung cancer. Nat. Commun. 2011. 2: 600.
45. Jauch, D., Martin, M., Schiechl, G., Kesselring, R., Schlitt, H. J., Geissler, E. K. and Fichtner-Feigl, S., Interleukin 21 controls tumour growth and tumour immunosurveillance in colitis-associated tumorigenesis in mice. Gut 2011. 60: 1678-1686.
46. Kesselring, R., Jauch, D. and Fichtner-Feigl, S., Interleukin 21 impairs tumor immunosurveillance of colitis-associated colorectal cancer. Oncoimmunology 2012. 1: 537-538.
47. Hahn, W. C. and Weinberg, R. A., Rules for making human tumor cells. N. Engl. J. Med. 2002. 347: 1593-1603.
48. Mathon, N. F. and Lloyd, A. C., Cell senescence and cancer. Nat. Rev. Cancer 2001. 1: 203-213.
49. Popivanova, B. K., Kitamura, K., Wu, Y., Kondo, T., Kagaya, T., Kaneko, S., Oshima, M. et al., Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J. Clin. Invest. 2008. 118: 560-570.
50. Gerber, S. A., Sedlacek, A. L., Cron, K. R., Murphy, S. P., Frelinger, J. G. and Lord, E. M., IFN-gamma mediates the antitumor effects of radiation therapy in a murine colon tumor. Am. J. Pathol. 2013. 2345-2354.
51. Jacobson-Brown, P. and Neuman, M. G., Colon polyps and cytokines: emerging immunological mechanisms. Rom. J. Gastroenterol. 2003. 12: 207-214.
52. Blatner, N. R., Mulcahy, M. F., Dennis, K. L., Scholtens, D., Bentrem, D. J., Phillips, J. D., Ham, S. et al., Expression of RORgammat marks a pathogenic regulatory T cell subset in human colon cancer. Sci. Transl. Med. 2012. 4: 164ra159.
53. Pacholczyk, R., Kraj, P. and Ignatowicz, L., Peptide specificity of thymic selection of CD4+CD25+ T cells. J. Immunol. 2002. 168: 613-620.
54. Addey, C., White, M., Dou, L., Coe, D., Dyson, J. and Chai, J. G., Functional plasticity of antigen-specific regulatory T cells in context of tumor. J. Immunol. 2011. 186: 4557-4564.
55. Pillai, M. R., Collison, L. W., Wang, X., Finkelstein, D., Rehg, J. E., Boyd, K., Szymczak-Workman, A. L. et al., The plasticity of regulatory T cell function. J. Immunol. 2011. 187: 4987-4997.
56. Obermeier, F., Kojouharoff, G., Hans, W., Scholmerich, J., Gross, V. and Falk, W., Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice. Clin. Exp. Immunol. 1999. 116: 238-245.
57. Weigmann, B., Tubbe, I., Seidel, D., Nicolaev, A., Becker, C. and Neurath, M. F., Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue. Nat. Protoc. 2007. 2: 2307-2311.